Related Experiment Videos
Graft rejection in sensitized recipients
1Harvard Medical School, Department of Surgery, Boston, USA.
Annals of Transplantation
|January 1, 1996
Summary
Recipient sensitization to major histocompatibility complex (MHC) antigens significantly complicates kidney transplantation. Understanding combined cellular and humoral immune responses is key to improving graft survival in highly sensitized patients.
Area of Science:
- Immunology
- Transplantation Science
- Clinical Medicine
Background:
- Recipient sensitization to MHC antigens is a major challenge in clinical transplantation.
- Approximately 20% of kidney transplant candidates have high levels of alloantibodies, increasing rejection risk.
- Current immunosuppressants struggle to control rejection in sensitized patients.
Purpose of the Study:
- To explore the immunological mechanisms underlying allograft rejection in presensitized recipients.
- To identify common pathways targeted by effective immunosuppressive therapies.
- To inform strategies for managing transplant rejection and advancing xenotransplantation.
Main Methods:
- Review of existing evidence on immune alloreactivity in transplantation.
- Analysis of the roles of cellular and humoral immunity in graft rejection.
- Examination of effector mechanisms targeting vascular endothelium.
Main Results:
- Combined cellular and humoral immune alloreactivity is central to rejection in sensitized hosts.
- Successful immunosuppression involves reducing mononuclear cell activation, cytokine expression, and endothelial cell activation.
- Vascular endothelium is a key target, affected by antibodies, complement, coagulation, and phagocytic cells.
Conclusions:
- A deeper understanding of the rejection cascade is crucial for managing sensitized transplant recipients.
- Insights gained may facilitate the development of novel immunosuppressive strategies.
- This research has implications for advancing xenotransplantation research.